RAN-Imipenem-Cilastatin (2015-12-23)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 2686433 | RAN-Imipenem-Cilastatin | - Recalling Firm
- Ranbaxy Pharmaceuticals Canada Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- CANADA
- Marketing Authorization Holder
- Ranbaxy Pharmaceuticals Canada Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- CANADA
| Powder for solution | DIN 02351692 | Cilastatin (Cilastatin Sodium) 250mg/vial |
Affected Products
RAN-Imipenem-Cilastatin
Out of specification result for an impurity during stability testing.
One wholesaler in Quebec distributing to hospitals.